JP2016512034A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512034A5
JP2016512034A5 JP2016502035A JP2016502035A JP2016512034A5 JP 2016512034 A5 JP2016512034 A5 JP 2016512034A5 JP 2016502035 A JP2016502035 A JP 2016502035A JP 2016502035 A JP2016502035 A JP 2016502035A JP 2016512034 A5 JP2016512034 A5 JP 2016512034A5
Authority
JP
Japan
Prior art keywords
human immunoglobulin
human
heavy chain
mouse
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502035A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512034A (ja
JP6529957B2 (ja
Filing date
Publication date
Priority claimed from US13/798,455 external-priority patent/US9796788B2/en
Application filed filed Critical
Priority claimed from PCT/US2014/026040 external-priority patent/WO2014160202A1/en
Publication of JP2016512034A publication Critical patent/JP2016512034A/ja
Publication of JP2016512034A5 publication Critical patent/JP2016512034A5/ja
Application granted granted Critical
Publication of JP6529957B2 publication Critical patent/JP6529957B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502035A 2013-03-13 2014-03-13 限られた免疫グロブリン軽鎖レパートリーを発現するマウス Active JP6529957B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/798,455 2013-03-13
US13/798,455 US9796788B2 (en) 2010-02-08 2013-03-13 Mice expressing a limited immunoglobulin light chain repertoire
PCT/US2014/026040 WO2014160202A1 (en) 2013-03-13 2014-03-13 Mice expressing a limited immunoglobulin light chain repertoire

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019006738A Division JP6790136B2 (ja) 2013-03-13 2019-01-18 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Publications (3)

Publication Number Publication Date
JP2016512034A JP2016512034A (ja) 2016-04-25
JP2016512034A5 true JP2016512034A5 (https=) 2017-06-01
JP6529957B2 JP6529957B2 (ja) 2019-06-12

Family

ID=50483561

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016502035A Active JP6529957B2 (ja) 2013-03-13 2014-03-13 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2019006738A Active JP6790136B2 (ja) 2013-03-13 2019-01-18 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2019148806A Active JP7010902B2 (ja) 2013-03-13 2019-08-14 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2020128111A Pending JP2020182490A (ja) 2013-03-13 2020-07-29 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019006738A Active JP6790136B2 (ja) 2013-03-13 2019-01-18 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2019148806A Active JP7010902B2 (ja) 2013-03-13 2019-08-14 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2020128111A Pending JP2020182490A (ja) 2013-03-13 2020-07-29 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Country Status (26)

Country Link
EP (4) EP4545567A3 (https=)
JP (4) JP6529957B2 (https=)
KR (2) KR102424756B1 (https=)
CN (2) CN108611369B (https=)
AU (3) AU2014244020B2 (https=)
BR (1) BR112015022034B1 (https=)
CA (1) CA2903698C (https=)
CY (1) CY1121545T1 (https=)
DK (2) DK3501272T5 (https=)
ES (3) ES2712207T3 (https=)
FI (1) FI3501272T3 (https=)
HR (2) HRP20190706T1 (https=)
HU (2) HUE044003T2 (https=)
IL (2) IL240563B (https=)
LT (2) LT2967013T (https=)
MX (3) MX377146B (https=)
PL (2) PL3501272T3 (https=)
PT (2) PT2967013T (https=)
RS (2) RS64185B1 (https=)
RU (1) RU2689664C2 (https=)
SG (2) SG10201801101QA (https=)
SI (2) SI2967013T1 (https=)
SM (2) SMT201900196T1 (https=)
TR (1) TR201901668T4 (https=)
WO (1) WO2014160202A1 (https=)
ZA (2) ZA201505835B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
SMT202600080T1 (it) 2010-02-08 2026-03-09 Regeneron Pharma Topo con catena leggera comune
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
HUE047278T2 (hu) 2011-08-05 2020-04-28 Regeneron Pharma Humanizált univerzális könnyûláncú egerek
SG11201401181YA (en) 2011-10-17 2014-04-28 Regeneron Pharma Restricted immunoglobulin heavy chain mice
ME03551B (me) 2012-06-12 2020-07-20 Regeneron Pharma Humanizovane nehumane živoтinje sa ograničenim lokusima imunoglobulinskog тeškog lanca
MY178882A (en) * 2013-02-20 2020-10-21 Regeneron Pharma Non-human animals with modified immunoglobulin heavy chain sequences
CA3124228C (en) 2014-03-21 2024-05-14 Regeneron Pharmaceuticals, Inc. Non-human animals that make single domain binding proteins
CA2979702A1 (en) 2015-03-19 2016-09-22 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
KR20230006929A (ko) 2016-01-13 2023-01-11 리제너론 파마슈티칼스 인코포레이티드 조작된 중쇄 다양성 영역을 갖는 설치류
CA3076632A1 (en) * 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof
IL318469A (en) 2018-06-14 2025-03-01 Regeneron Pharma Non-human animals capable of reorganizing transgenic DH-DH, and their uses
US12467062B2 (en) 2018-12-21 2025-11-11 Compass Therapeutics Llc Transgenic mouse expressing common human light chain
CA3125380A1 (en) 2019-02-18 2020-08-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animals with humanized immunoglobulin locus
BR112021016173A2 (pt) 2019-02-22 2021-11-03 Regeneron Pharma Roedor geneticamente modificado, métodos de produção de um roedor geneticamente modificado e de produção de um anticorpo anti-nav1.7, célula ou tecido isolado de roedor, linhagem celular imortalizada, embrião de roedor, construto de ácido nucleico de direcionamento, e, hibridoma
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
JP2023529846A (ja) 2020-06-02 2023-07-12 バイオサイトジェン ファーマシューティカルズ (ベイジン) カンパニー リミテッド 共通軽鎖免疫グロブリン遺伝子座を有する遺伝子改変非ヒト動物
IL303865A (en) 2020-12-23 2023-08-01 Regeneron Pharma Methods for obtaining antibodies that bind transmembrane proteins and cells that produce them
CA3165366A1 (en) 2020-12-23 2022-06-30 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
CN114736927A (zh) * 2022-05-19 2022-07-12 东北大学 一种单抗克隆与表达载体的构建及应用
TW202430641A (zh) * 2023-01-18 2024-08-01 美商基利科學股份有限公司 人類免疫球蛋白二元輕鏈轉殖基因構築體及其用途
WO2026019824A1 (en) * 2024-07-16 2026-01-22 Gilead Sciences, Inc. Human immunoglobulin common light chain transgene constructs and uses thereof
CN121628915A (zh) * 2024-08-29 2026-03-10 上海泰槿生物技术有限公司 产生限制的免疫球蛋白轻链库的细胞、动物和方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041871B1 (en) * 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7217797B2 (en) 2002-10-15 2007-05-15 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
ES2473596T3 (es) * 2003-07-15 2014-07-07 Therapeutic Human Polyclonals, Inc. Loci de inmunoglobulina humanizada
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
AU2007235496B2 (en) * 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
JP5307708B2 (ja) 2006-06-02 2013-10-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトil−6受容体に対する高親和性抗体
ITMI20071522A1 (it) * 2007-07-27 2009-01-28 Areta Internat S R L Vaccino idiotipico
EP2147594B1 (en) * 2008-06-27 2013-11-13 Merus B.V. Antibody producing non-human mammals
JP5827127B2 (ja) * 2008-12-18 2015-12-02 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム ヒト化抗体を発現する非ヒトトランスジェニック動物及びその使用
MY192182A (en) 2009-06-26 2022-08-04 Regeneron Pharma Readily isolated bispecific antibodies with native immunoglobulin format
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
US20130045492A1 (en) * 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
SMT202600080T1 (it) * 2010-02-08 2026-03-09 Regeneron Pharma Topo con catena leggera comune
PT3034608T (pt) * 2010-06-22 2019-05-28 Regeneron Pharma Ratinhos expressando uma cadeia leve híbrida de imunoglobulina com uma região variável humana
SMT201700023T1 (it) * 2010-08-02 2017-03-08 Regeneron Pharma Topi che producono proteine leganti vl
RU2460287C1 (ru) * 2011-03-29 2012-09-10 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Трансгенная мышь, предназначенная для моделирования состояний, угрожающих развитием синдрома внезапной сердечной смерти при дистрофин-дефицитной кардиомиопатии
HUE047278T2 (hu) * 2011-08-05 2020-04-28 Regeneron Pharma Humanizált univerzális könnyûláncú egerek
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals

Similar Documents

Publication Publication Date Title
JP2016512034A5 (https=)
JP2018138047A5 (https=)
RU2015143110A (ru) Мыши, экспрессирующие ограниченный репертуар легких цепей иммуноглобулина
JP2015519055A5 (https=)
JP2015525071A5 (https=)
JP2014110814A5 (https=)
JP2017114866A5 (https=)
JP2015519076A5 (https=)
JP2020501516A5 (https=)
JP2010529042A5 (https=)
SI2840892T1 (en) Animals other than humans with modified immunoglobulin heavy chain sequences
JP2013538057A5 (https=)
RU2014153674A (ru) Способ получения полностью человеческих биспецифических антител с применением общей легкой цепи
JP2015510767A5 (https=)
JP2015505477A5 (https=)
RU2021129958A (ru) Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина
JP2020504101A5 (https=)
JP2020530760A5 (https=)
JP2014524243A5 (https=)
JP2020535799A5 (https=)
JP2014524733A5 (https=)
JP2013535213A5 (https=)
HRP20190897T1 (hr) Laki lanac humaniziranih miševa
JP2015508056A5 (https=)
JP2017509355A5 (https=)